biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > This is why i love this board

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 23, 2023 7:17pm

88 Views

Post# 35241069

RE:This is why i love this board

And I love prophetofabsurdity's excuse that BTI is hindered because biotechs are not in favor right now. Oh really? What about a few years ago when biotechs were in one of the biggest bull markets ever? Almost every day you'd wake up to a small biotech company announcing a lucrative partnership with a bigger company. Just hinting any clinical or even pre clinical success would send the stock flying. And what did BTI do during that time? Nothing at all.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide